Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
enVVeno MedicalNVNOW 30 12-1 Month Momentum % is N/A% as of Sep. 09, 2026. GuruFocus rates NVNOW with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 825 Medical Devices & Instruments companies, enVVeno Medical ranks worse than 89.58% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-09), enVVeno Medical's 12-1 Month Momentum % is N/A%.
The industry rank for enVVeno Medical's 12-1 Month Momentum % or its related term are showing as below:
NVNOW's 12-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -18.45 * Ranked among companies with meaningful 12-1 Month Momentum % only.
enVVeno Medical (NAS:NVNOW) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
enVVeno Medical 12-1 Month Momentum % Related Terms
NVNOW vs ICCM, TRIB, AIDX: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, enVVeno Medical's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
enVVeno Medical 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where enVVeno Medical's 12-1 Month Momentum % falls into.
enVVeno Medical (NAS:NVNOW) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
enVVeno Medical (NVNOW) has a 12-1 Month Momentum % of N/A% as of Sep. 09, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on enVVeno Medical and its competitors. According to the industry distribution chart, enVVeno Medical ranks #739 out of 825 companies in the Medical Devices & Instruments industry, placing it in the top 89.6%.
Is enVVeno Medical's 12-1 Month Momentum % too high?
enVVeno Medical's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, enVVeno Medical ranks #739 out of 825 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, enVVeno Medical has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's 12-1 Month Momentum % compare to ICCM and TRIB?
According to the Medical Devices & Instruments industry distribution chart, enVVeno Medical ranks #739 out of 825 companies for 12-1 Month Momentum %. This places enVVeno Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on enVVeno Medical and its competitors. enVVeno Medical's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNOW) has a current 12-1 Month Momentum % of N/A%. The current 12-1 Month Momentum % is N/A%. enVVeno Medical's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For enVVeno Medical (NVNOW), the current 12-1 Month Momentum % is N/A% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
30GF Score
Get the complete analysis for NVNOW
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVNOW has been successfully added to your 
